BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Li Q, Dhyani M, Grajo JR, Sirlin C, Samir AE. Current status of imaging in nonalcoholic fatty liver disease. World J Hepatol 2018; 10(8): 530-542 [PMID: 30190781 DOI: 10.4254/wjh.v10.i8.530]
URL: https://www.wjgnet.com/1948-5182/full/v10/i8/530.htm
(401) (421) (0) (0) (7) (3) (52121) (207)
Number Citing Articles
1
Aliza Gross, Marcia Lange, Emma Rosenbluth, Carin Carroll, Rhoda Sperling, Courtney Juliano, Keith Sigel, Scott L. Friedman, Pamela A. Argiriadi, Jaime Chu, Tatyana Kushner. Evaluation of 2-year outcomes in infants born to mothers with and without NAFLD in pregnancy. European Journal of Pediatrics 2023; 182(8) doi: 10.1007/s00431-023-05044-7
2
Isabel Molwitz, Graeme Michael Campbell, Tobias Knopp, Niklas Schubert, Jennifer Erley, Anastassia Löser, Gerhard Adam, Jin Yamamura, Roland Fischer, Ann-Kathrin Ozga, Patryk Szwargulski, Pascal A. T. Baltzer. Fat quantification in dual-layer detector spectral CT: How to handle iron overload, varying tube voltage and radiation dose Indices. PLOS ONE 2024; 19(5) doi: 10.1371/journal.pone.0302863
3
Rui Zhan, Yuhao Chen, Yue Gu, Yajie Chen, Kaixuan Ren, Tianxiang Zhou. The correlation between hepatic fat fraction on dual-energy CT and epicardial adipose tissue in patients with non-alcoholic fatty liver disease. Journal of Radiation Research and Applied Sciences 2025; 18(2) doi: 10.1016/j.jrras.2025.101325
4
Avishek Mandal. Cattle Diseases - Molecular and Biochemical Approach. Veterinary Medicine and Science 2023; 16 doi: 10.5772/intechopen.108151
5
Katherine J. P. Schwenger, Maryam Alali, Yasaman Ghorbani, Sandra E. Fischer, Timothy D. Jackson, Allan Okrainec, Johane P. Allard. Reliability of Non-invasive Liver Fibrosis Assessment Tools Versus Biopsy in Pre- and Post-bariatric Surgery Patients with Non-alcoholic Fatty Liver Disease. Obesity Surgery 2023; 33(1) doi: 10.1007/s11695-022-06380-7
6
Jiahui Yong, Huiru Wang, Lei Liu, Haodong Zhao, Chen Sun, Shuomin Wang, Panquan Luo, Yunhong Xia, Baicheng Ding. Association between triglyceride-glucose-related indices and the prevalence of MAFLD/MASLD and hepatic fibrosis in American adults: an analysis of NHANES data. Critical Public Health 2026; 36(1) doi: 10.1080/09581596.2026.2664251
7
Jin‐Li Wang, Jian Dong, Si‐Rui Wang, Chun‐Li Cao, Jin Tong, WenXiao Li, Ting‐Ting Du, Ting‐Ting He, Xiao‐Wu Yuan, Jun Li, Hong Zhai. Reliability of Ultrasonic Hepatorenal Indices in Assessing Hepatic Steatosis: A Systematic Review and Meta‐Analysis. Journal of Clinical Ultrasound 2026; 54(1) doi: 10.1002/jcu.70006
8
Man Zhang. Imaging Biomarkers for Nonalcoholic Fatty Liver Disease. Academic Radiology 2019; 26(7) doi: 10.1016/j.acra.2019.04.001
9
Angeliki M. Angelidi, Angeliki Papadaki, Eric Nolen-Doerr, Chrysoula Boutari, Christos S. Mantzoros. The effect of dietary patterns on non-alcoholic fatty liver disease diagnosed by biopsy or magnetic resonance in adults: a systematic review of randomised controlled trials. Metabolism 2022; 129 doi: 10.1016/j.metabol.2022.155136
10
Haoxuan Zou, Wen Pan, Xiaobin Sun. Assessment of the diagnostic efficacy of five non-invasive tests for MASLD: external validation utilizing data from two cohorts. Frontiers in Nutrition 2025; 12 doi: 10.3389/fnut.2025.1571487
11
Reham M. Gameaa, Nehad Hawash, Rehab Badawi, Sherief Abd-Elsalam, Gamal K. Kasem, El-Sayed A. Wasfy. Assessment of Hepatic Steatosis in Patients with Chronic Hepatitis B Using Fibroscan and its Relation to Insulin Resistance. The Open Biomarkers Journal 2019; 9(1) doi: 10.2174/1875318301909010070
12
Maryam Ghadimi, Roya Rezvani Habibabadi, Bita Hazhirkarzar, Mohammadreza Shaghaghi, Sanaz Ameli, Pegah Khoshpouri, Mounes Aliyari Ghasabeh, Ahmet Gurakar, Timothy M. Pawlik, Ihab R. Kamel. Advances in Imaging of Diffuse Parenchymal Liver Disease. Journal of Clinical Gastroenterology 2020; 54(8) doi: 10.1097/MCG.0000000000001380
13
Yoo Bin Seo, A Lum Han. Association of the Serum Uric Acid-to-Creatinine Ratio with Nonalcoholic Fatty Liver Disease Diagnosed by Computed Tomography. Metabolic Syndrome and Related Disorders 2021; 19(2) doi: 10.1089/met.2020.0086
14
Elizabeth Aguilar, Edgar Guevara, Guadalupe Donjuán-Loredo, Ricardo Espinosa-Tanguma, Roberto Salgado Delgado, Miguel G. Ramírez-Elías. Analysis of Non-Alcoholic Fatty Liver Through Intensity Maps Applying Raman Spectroscopy. Biophotonics Congress: Optics in the Life Sciences 2023 (OMA, NTM, BODA, OMP, BRAIN) 2023;  doi: 10.1364/BODA.2023.DW4A.4
15
Q. Li, T. Cui, H. Ding, X. Shi, Y. Zhang, P. Jiang, J. Han, J. Li, J. Liu. Exploring the correlation between high-risk coronary plaque and hepatic fat fraction in non-alcoholic fatty liver disease using spectral computed tomography (CT). Clinical Radiology 2025; 86 doi: 10.1016/j.crad.2025.106943
16
Danoob Dalili, Alberto Bazzocchi, Daniel E. Dalili, Giuseppe Guglielmi, Amanda Isaac. The role of body composition assessment in obesity and eating disorders. European Journal of Radiology 2020; 131 doi: 10.1016/j.ejrad.2020.109227
17
Matti O. Ruuskanen, Fredrik Åberg, Ville Männistö, Aki S. Havulinna, Guillaume Méric, Yang Liu, Rohit Loomba, Yoshiki Vázquez-Baeza, Anupriya Tripathi, Liisa M. Valsta, Michael Inouye, Pekka Jousilahti, Veikko Salomaa, Mohit Jain, Rob Knight, Leo Lahti, Teemu J. Niiranen. Links between gut microbiome composition and fatty liver disease in a large population sample. Gut Microbes 2021; 13(1) doi: 10.1080/19490976.2021.1888673
18
Andrea Salmi, Luigi di Filippo, Clarissa Ferrari, Stefano Frara, Andrea Giustina. Ultrasound and FibroScan® Controlled Attenuation Parameter in patients with MAFLD: head to head comparison in assessing liver steatosis. Endocrine 2022; 78(2) doi: 10.1007/s12020-022-03157-x
19
Haoxuan Zou, Fanrong Zhao, Xiuhe Lv, Xiaopu Ma, Yan Xie. Development and validation of a new nomogram to screen for MAFLD. Lipids in Health and Disease 2022; 21(1) doi: 10.1186/s12944-022-01748-1
20
Andrew J. Krentz, Pierre Bedossa. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease. 2019;  doi: 10.1007/978-3-030-11748-1_10
21
Hwi Seung Kim, Yun Kyung Cho, Eun Hee Kim, Min Jung Lee, Chang Hee Jung, Joong-Yeol Park, Hong-Kyu Kim, Woo Je Lee. Triglyceride Glucose-Waist Circumference Is Superior to the Homeostasis Model Assessment of Insulin Resistance in Identifying Nonalcoholic Fatty Liver Disease in Healthy Subjects. Journal of Clinical Medicine 2021; 11(1) doi: 10.3390/jcm11010041
22
Hongzhu Wen, Hongyong Deng, Lili Yang, Lujin Li, Jiang Lin, Peiyong Zheng, Milica Bjelakovic, Guang Ji. Vitamin E for people with non-alcoholic fatty liver disease. Cochrane Database of Systematic Reviews 2024; 2024(10) doi: 10.1002/14651858.CD015033.pub2
23
Azin S. Janani, Sasan Ahdi Rezaeieh, Amin Darvazehban, Ali Zamani, Aida Brankovic, Beadaa Mohammed, Graeme A. Macdonald, Amin M. Abbosh. Hepatic Steatosis Detection Using Differential Effective Permittivity. IEEE Transactions on Antennas and Propagation 2021; 69(12) doi: 10.1109/TAP.2021.3090508
24
Prerna Goyal, Rahul Chopra, Omesh Goyal. Do Hepatic Fibrosis and Steatosis Measured by Hepatic Transient Elastography (FibroScan) Predict Cardiovascular Risk in Patients with Non-alcoholic Fatty Liver Disease: An Observational Cross-sectional Study. Indian Journal of Cardiovascular Disease in Women 2024; 9 doi: 10.25259/IJCDW_2_2024
25
Ekram W. Abd El-Wahab, Rehab A. Zein El-Abedin, Walid M. Ahmed, Hanan Z. Shatat. Validation of a Non-Laboratory Based Screening Tool for Predicting Non-Alcoholic Fatty Liver Disease in an Egyptian Setting. The American Journal of the Medical Sciences 2020; 360(6) doi: 10.1016/j.amjms.2020.06.020
26
Prevalence and Predictors of Nonalcoholic Fatty Liver Disease in Family Members of Patients With Nonalcoholic Fatty Liver Disease. Journal of Clinical and Experimental Hepatology 2022; 12(2) doi: 10.1016/j.jceh.2021.07.013
27
Parinda Prathyajuta, Thaninee Prasoppokakorn, Kessarin Thanapirom, Pattharasai Kachornvitaya, Kanokwan Sonsiri, Chonlada Phathong, Arth Khemtong, Suthep Udomsawaengsup, Sombat Treeprasertsuk. Liver Fibrosis Tests and Outcomes of Bariatric Surgery in Morbidly Obese Patients With MASLD. Portal Hypertension & Cirrhosis 2026; 5(1) doi: 10.1002/poh2.70034
28
E. V. Biryukova. Non-alcoholic fatty liver disease: a current challenge of interdisciplinary research. Meditsinskiy sovet = Medical Council 2024; (6) doi: 10.21518/ms2024-159
29
Nirmalya Sinha, Saptarshi Mukhopadhyay, Manabendra Sau. Metabolic syndrome is not uncommon among lean non-alcoholic fatty liver disease patients as compared with those with obesity. Indian Journal of Gastroenterology 2020; 39(1) doi: 10.1007/s12664-020-01020-3
30
Cristina M. Muzica, Catalin Sfarti, Anca Trifan, Sebastian Zenovia, Tudor Cuciureanu, Robert Nastasa, Laura Huiban, Camelia Cojocariu, Ana-Maria Singeap, Irina Girleanu, Stefan Chiriac, Carol Stanciu, Branka Filipović. Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: A Bidirectional Relationship. Canadian Journal of Gastroenterology and Hepatology 2020; 2020 doi: 10.1155/2020/6638306
31
P.-Y. Brillet. Dépistage du cancer broncho-pulmonaire: les « big 3 » et les autres. Revue des Maladies Respiratoires Actualités 2019; 11(2) doi: 10.1016/S1877-1203(19)30041-2
32
Xinting Cai, Susanne Rospleszcz, Birger Mensel, Ulf Schminke, Jens-Peter Kühn, Ali Alexander Aghdassi, Corinna Storz, Roberto Lorbeer, Christopher L Schlett, Wolfgang Rathmann, Michael Roden, Simon Hohenester, Robin Bülow, Fabian Bamberg, Annette Peters, Barbara Thorand, Henry Völzke, Jana Nano. Association between hepatic fat and subclinical vascular disease burden in the general population. BMJ Open Gastroenterology 2021; 8(1) doi: 10.1136/bmjgast-2021-000709
33
Parag V Patil, Sravya Julakanti, Rajshree U Dhadve. Point Shear Wave Elastography for Assessment of Liver Stiffness in Normal Individuals and in Patients With Non-alcoholic Fatty Liver Disease. Cureus 2024;  doi: 10.7759/cureus.70711
34
Anne Flint, Grit Andersen, Paul Hockings, Lars Johansson, Anni Morsing, Mads Sundby Palle, Thomas Vogl, Rohit Loomba, Leona Plum‐Mörschel. Randomised clinical trial: semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non‐alcoholic fatty liver disease assessed by magnetic resonance imaging. Alimentary Pharmacology & Therapeutics 2021; 54(9) doi: 10.1111/apt.16608
35
Jeong-Ju Yoo, Yong Seok Lim, Min Sung Kim, Bora Lee, Bo-Yeon Kim, Zisun Kim, Ji Eun Lee, Min Hee Lee, Sang Gyune Kim, Young Seok Kim, Hakan Buyukhatipoglu. Risk of fatty liver after long-term use of tamoxifen in patients with breast cancer. PLOS ONE 2020; 15(7) doi: 10.1371/journal.pone.0236506
36
Hui Che, Sumana Ramanathan, David J. Foran, John L. Nosher, Vishal M. Patel, Ilker Hacihaliloglu. Simplifying Medical Ultrasound. Lecture Notes in Computer Science 2021; 12967 doi: 10.1007/978-3-030-87583-1_18
37
Fatemeh Homayounieh, Sanjay Saini, Leila Mostafavi, Ruhani Doda Khera, Michael Sühling, Bernhard Schmidt, Ramandeep Singh, Thomas Flohr, Mannudeep K. Kalra. Accuracy of radiomics for differentiating diffuse liver diseases on non-contrast CT. International Journal of Computer Assisted Radiology and Surgery 2020; 15(10) doi: 10.1007/s11548-020-02212-0
38
Azin Momeni, Maryam Yazdi, Mohammad Esmail Motlagh, Mostafa Qorbani, Roya Kelishadi. Glucose and lipid-related indicators in relation to elevated alanine aminotransferase in a pediatric population. Journal of Pediatric Endocrinology and Metabolism 2024; 37(7) doi: 10.1515/jpem-2024-0092
39
William Wood, Treiy Tinich, Lauren Lazar, Gary R. Schooler, Meghana Sathe. Cystic fibrosis hepatobiliary involvement: an update on imaging in diagnosis and monitoring. Pediatric Radiology 2024; 54(9) doi: 10.1007/s00247-024-05979-5
40
Jacob Beiriger, Kashyap Chauhan, Adnan Khan, Taha Shahzad, Natalia Salinas Parra, Peter Zhang, Sarah Chen, Anh Nguyen, Brian Yan, John Bruckbauer, Dina Halegoua-DeMarzio. Advancements in Understanding and Treating NAFLD: A Comprehensive Review of Metabolic-Associated Fatty Liver Disease and Emerging Therapies. Livers 2023; 3(4) doi: 10.3390/livers3040042
41
Maija Radzina, Davis Simanis Putrins, Arta Micena, Ieva Vanaga, Oksana Kolesova, Ardis Platkajis, Ludmila Viksna. Post‐COVID‐19 Liver Injury: Comprehensive Imaging With Multiparametric Ultrasound. Journal of Ultrasound in Medicine 2022; 41(4) doi: 10.1002/jum.15778
42
Varun Damle, Akarshan Sharma, Brijendra Kumar Srivastava, Viswanathan Mohan. Imaging Modalities for Hepatic Steatosis and Fibrosis in Type 2 Diabetes Mellitus: A Review Article. Journal of Diabetology 2026; 17(1) doi: 10.4103/jod.jod_68_25
43
Narsimha Keetha Rao, Shahriar Ghodous, Anoop Gurram, Mehrdad Khorasani, Madhusudhan Ponnala, Arman Habibi, Kwame Agyeman, Parsa Saberian, Pubali Biswas, Negin Letafatkar, Simran Joshi, Yasmin Sahli, Reza Amani-Beni, Bahar Darouei, Yussif Issaka, Kiran Sandilya Balivada, Farahnaz Joukar, Amir Nasrollahizadeh, Anderson Ogazi, Mohammad Amin Karimi, Michael T Ulrich, Mohammad-Hossein Keivanlou, Mohammad-Javad Khosousi, Seyyed Mohammad Hashemi, Ehsan Amini-Salehi, Sandeep S Nayak. Prevalence and Associated Factors of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Disease: An Updated Global Systematic Review and Meta-Analysis of over 1.5 Million Individuals. Inflammatory Bowel Diseases 2026; 32(2) doi: 10.1093/ibd/izaf226
44
Muhammad Shahzeb Khan, Syed Sarmad Javaid, Amreen Dinani, Kara Wegermann, Ambarish Pandey, Ankeet S. Bhatt, Mark Muthiah, Harriette G.C. Van Spall, Faiez Zannad, Javed Butler, Michael L. Volk, Marat Fudim. The Basics of Metabolic Dysfunction–Associated Steatotic Liver Disease for Cardiologists. JACC 2025; 86(20) doi: 10.1016/j.jacc.2025.08.100
45
Shuqin Chen, Yong Jin, Miao Xu, Pingping Zhang, Ye Zhou, Xingjun Qian, Qifa Song, Shizhong Bu, Jing Sun, Li Li. Relationship Between Thyroid Hormone and Liver Steatosis Analysis Parameter in Obese Participants: A Case-Control Study. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2022;  doi: 10.2147/DMSO.S356882
46
Preetpal Singh, Ravinder Singh, Chirag Pasricha, Pratima Kumari. Navigating liver health with metabolomics: A comprehensive review. Clinica Chimica Acta 2025; 566 doi: 10.1016/j.cca.2024.120038
47
Akira YAMADA, Eriko YOSHIZAWA. Quantitative assessment of liver steatosis using ultrasound: dual-energy CT. Choonpa Igaku 2023; 50(3) doi: 10.3179/jjmu.JJMU.R.222
48
Queralt Martín-Saladich, Juan M. Pericàs, Andreea Ciudin, Clara Ramirez-Serra, Manuel Escobar, Jesús Rivera-Esteban, Santiago Aguadé-Bruix, Miguel A. González Ballester, José Raul Herance. Metabolic-associated fatty liver voxel-based quantification on CT images using a contrast adapted automatic tool. Medical Image Analysis 2024; 95 doi: 10.1016/j.media.2024.103185
49
Stefano Ballestri, Fabio Nascimbeni, Simonetta Lugari, Amedeo Lonardo, Giampiero Francica. A critical appraisal of the use of ultrasound in hepatic steatosis. Expert Review of Gastroenterology & Hepatology 2019; 13(7) doi: 10.1080/17474124.2019.1621164
50
Rui Zhan, Rongxing Qi, Sheng Huang, Yang Lu, Xiaoyu Wang, Jiashen Jiang, Xiwu Ruan, Anyi Song. The correlation between hepatic fat fraction evaluated by dual-energy computed tomography and high-risk coronary plaques in patients with non-alcoholic fatty liver disease. Japanese Journal of Radiology 2021; 39(8) doi: 10.1007/s11604-021-01113-9
51
David T. Fetzer, Ivan M. Rosado-Mendez, Michael Wang, Michelle L. Robbin, Arinc Ozturk, Keith A. Wear, Juvenal Ormachea, Timothy A. Stiles, J. Brian Fowlkes, Timothy J. Hall, Anthony E. Samir. Pulse-Echo Quantitative US Biomarkers for Liver Steatosis: Toward Technical Standardization. Radiology 2022; 305(2) doi: 10.1148/radiol.212808
52
Jitka Starekova, Scott B. Reeder. Liver fat quantification: where do we stand?. Abdominal Radiology 2020; 45(11) doi: 10.1007/s00261-020-02783-1
53
Artem Kaliaev, Wilson Chavez, Jorge Soto, Fahimul Huda, Hua Xie, Man Nguyen, Vijay Shamdasani, Stephan Anderson. Quantitative Ultrasound Assessment of Hepatic Steatosis. Journal of Clinical and Experimental Hepatology 2022; 12(4) doi: 10.1016/j.jceh.2022.01.007
54
Zhijie Li, Qianhua Li, Yijia Liu, Yao Chen, Jinzheng Zhang, Haiyan Zhang, Guoqiang Feng. In Situ Imaging of Extracellular Vesicles and Non-Alcoholic Fatty Liver Disease with a Near-Infrared Fluorescent Viscosity Probe. Analytical Chemistry 2025; 97(35) doi: 10.1021/acs.analchem.5c02797
55
Yong-Giun Kim, Gyung-Min Park, Seung Bum Lee, Dong Hyun Yang, Joon-Won Kang, Tae-Hwan Lim, Hong-Kyu Kim, Jaewon Choe, Seung-Whan Lee, Young-Hak Kim. Association of gamma-glutamyl transferase with subclinical coronary atherosclerosis and cardiac outcomes in non-alcoholics. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-75078-6
56
Hui Che, Lloyd G. Brown, David J. Foran, John L. Nosher, Ilker Hacihaliloglu. Liver disease classification from ultrasound using multi-scale CNN. International Journal of Computer Assisted Radiology and Surgery 2021; 16(9) doi: 10.1007/s11548-021-02414-0
57
A. Lum Han, Hee Kyung Lee. Comparison of the Diagnostic Performance of Steatosis Indices for Discrimination of CT-Diagnosed Metabolic Dysfunction-Associated Fatty Liver Disease. Metabolites 2022; 12(7) doi: 10.3390/metabo12070664
58
Brandon Havranek, Rebecca Loh, Beatriz Torre, Rachel Redfield, Dina Halegoua-DeMarzio. Glucagon-like peptide-1 receptor agonists improve metabolic dysfunction-associated steatotic liver disease outcomes. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-89408-z
59
Alyson Kaplan, Tracey G. Simon, Jacqueline B. Henson, Thomas Wang, Hui Zheng, Stephanie A. Osganian, Russell Rosenblatt, Jordan Lake, Kathleen E. Corey. Brief Report: Relationship Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease in Persons With HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes 2020; 84(4) doi: 10.1097/QAI.0000000000002359
60
Roberta Catania, Alessandro Furlan, Andrew D. Smith, Jaideep Behari, Mitchell E. Tublin, Amir A. Borhani. Diagnostic value of MRI-derived liver surface nodularity score for the non-invasive quantification of hepatic fibrosis in non-alcoholic fatty liver disease. European Radiology 2021; 31(1) doi: 10.1007/s00330-020-07114-y
61
Hong Huang, Yong Liu, Qiuju Xiong, Yuanxiu Xing, Honglei Du. A fatty liver diseases classification network based on adaptive coordination attention with label smoothing. Biomedical Signal Processing and Control 2023; 86 doi: 10.1016/j.bspc.2023.105267
62
Manu V. Chakravarthy, Mohammad S. Siddiqui, Mikael F. Forsgren, Arun J. Sanyal. Harnessing Muscle–Liver Crosstalk to Treat Nonalcoholic Steatohepatitis. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.592373
63
José Timaná, Hector Chahuara, Lokesh Basavaraiappa, Adrian Basarab, Kenneth Hoyt, Roberto Lavarello. Feasibility of Attenuation Coefficient and Envelope Signal-to-Noise Ratio Estimation for Tissue Characterization of Liver Steatosis. 2022 IEEE International Ultrasonics Symposium (IUS) 2022;  doi: 10.1109/IUS54386.2022.9957945
64
Fatih Eren, Eda Kaya, Yusuf Yilmaz. Accuracy of Fibrosis-4 index and non-alcoholic fatty liver disease fibrosis scores in metabolic (dysfunction) associated fatty liver disease according to body mass index: failure in the prediction of advanced fibrosis in lean and morbidly obese individuals. European Journal of Gastroenterology & Hepatology 2022; 34(1) doi: 10.1097/MEG.0000000000001946
65
Pantajaree Hiranrat, Surachate Siripongsakun, Kamonwan Soonklang. Correlation of ultrasound attenuation imaging versus MRI proton density fat fraction in non-alcoholic fatty liver. The ASEAN Journal of Radiology 2022; 23(3) doi: 10.46475/aseanjr.v23i3.185
66
Azin Janani, Sasan Ahdi Rezaeieh, Amin Darvazehban, Mojtaba Khosravi-Farsani, Shelley Keating, Amin Abbosh. Electromagnetic Method for Steatotic Liver Detection Using Contrast in Effective Dispersive Permittivity. IEEE Journal of Electromagnetics, RF and Microwaves in Medicine and Biology 2022; 6(3) doi: 10.1109/JERM.2022.3147358
67
Evy Yunihastuti, Lusiani Rusdi, Muhammad Syahrir Azizi, Riwanti Estiasari, Chyntia Olivia Maurine Jasirwan, Endah Ayu T. Wulandari, Dyah Purnamasari, Mutiara Shinta Noviar, Sally Aman Nasution. Effect of atorvastatin on subclinical atherosclerosis in virally-suppressed HIV-infected patients with CMV seropositivity: a randomized double-blind placebo-controlled trial. F1000Research 2023; 10 doi: 10.12688/f1000research.28262.2
68
Michelle C. M. Lee, Jacob J. Kachura, Paraskevi A. Vlachou, Raissa Dzulynsky, Amy Di Tomaso, Haider Samawi, Nancy Baxter, Christine Brezden-Masley. Evaluation of Adjuvant Chemotherapy-Associated Steatosis (CAS) in Colorectal Cancer. Current Oncology 2021; 28(4) doi: 10.3390/curroncol28040265
69
José Timaná, Hector Chahuara, Lokesh Basavarajappa, Adrian Basarab, Kenneth Hoyt, Roberto Lavarello. Simultaneous imaging of ultrasonic relative backscatter and attenuation coefficients for quantitative liver steatosis assessment. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-33964-9
70
Haoxuan Zou, Xiaopu Ma, Wen Pan, Yan Xie. The association of the metabolic score for insulin resistance and metabolic dysfunction-related steatosis liver disease: a population-based observational study. European Journal of Medical Research 2025; 30(1) doi: 10.1186/s40001-025-02936-2
71
Giuseppe V. Toia, Achille Mileto, Carolyn L. Wang, Dushyant V. Sahani. Quantitative dual-energy CT techniques in the abdomen. Abdominal Radiology 2021; 47(9) doi: 10.1007/s00261-021-03266-7
72
Waqas B. Khalid, Nadim Farhat, Linda Lavery, Josh Jarnagin, James P. Delany, Kang Kim. Non-invasive Assessment of Liver Fat in ob/ob Mice Using Ultrasound-Induced Thermal Strain Imaging and Its Correlation with Hepatic Triglyceride Content. Ultrasound in Medicine & Biology 2021; 47(4) doi: 10.1016/j.ultrasmedbio.2020.12.014
73
Jeffrey Budd, Kenneth Cusi. Nonalcoholic Fatty Liver Disease: What Does the Primary Care Physician Need to Know?. The American Journal of Medicine 2020; 133(5) doi: 10.1016/j.amjmed.2020.01.007
74
C. Saravanakumar, M. Prakash, A. Deepak Kumar, C. Ashokkumar. Intelligent Computing, Smart Communication and Network Technologies. Communications in Computer and Information Science 2024; 1970 doi: 10.1007/978-3-031-75957-4_32
75
Mahdi Barazesh, Sajad Jalili, Morteza Akhzari, Fouzieyeh Faraji, Ebrahim Khorramdin. Recent Progresses on Pathophysiology, Diagnosis, Therapeutic Modalities, and Management of Non-alcoholic Fatty Liver Disorder. Current Drug Therapy 2024; 19(1) doi: 10.2174/1574885518666230417111247
76
Solène Marie, David K.K. Tripp, Nathan J. Cherrington. Strategies to Diagnose Nonalcoholic Steatohepatitis: A Novel Approach to Take Advantage of Pharmacokinetic Alterations. Drug Metabolism and Disposition 2022; 50(4) doi: 10.1124/dmd.121.000413
77
Tasnim Alkayyali, Lubna Qutranji, Eda Kaya, Alev Bakir, Yusuf Yilmaz. Clinical utility of noninvasive scores in assessing advanced hepatic fibrosis in patients with type 2 diabetes mellitus: a study in biopsy-proven non-alcoholic fatty liver disease. Acta Diabetologica 2020; 57(5) doi: 10.1007/s00592-019-01467-7
78
A. P. Gonchar, V. A. Gombolevskij, A. B. Elizarov, N. S. Kulberg, V. G. Klyashtorny, V. Yu. Chernina, V. Yu. Bosin, S. P. Morozov. Liver density in routine and low-dose computed tomography: the effect of image noise on measurement accuracy. Medical Visualization 2020; 24(1) doi: 10.24835/1607-0763-2020-1-39-47
79
Gavin Huangfu, Biyanka Jaltotage, Jing Pang, Nick S.R. Lan, Arun Abraham, Jacobus Otto, Abdul R. Ihdayhid, James M. Rankin, Benjamin J.W. Chow, Gerald F. Watts, Oyekoya T. Ayonrinde, Girish Dwivedi. Hepatic fat as a novel marker for high-risk coronary atherosclerotic plaque features in familial hypercholesterolaemia. Metabolism 2023; 139 doi: 10.1016/j.metabol.2022.155370
80
Ahmad Khonche, Hasan Fallah Huseini, Mahdi Gholamian, Reza Mohtashami, Farzaneh Nabati, Saeed Kianbakht. Standardized Nigella sativa seed oil ameliorates hepatic steatosis, aminotransferase and lipid levels in non-alcoholic fatty liver disease: A randomized, double-blind and placebo-controlled clinical trial. Journal of Ethnopharmacology 2019; 234 doi: 10.1016/j.jep.2019.01.009
81
Weijia Xu, Senyao Liu, Zhaoming Chen, Fapu Wu, Wenwen Cao, Yang Tian, Hu Xiong. Bichromatic Imaging with Hemicyanine Fluorophores Enables Simultaneous Visualization of Non-alcoholic Fatty Liver Disease and Metastatic Intestinal Cancer. Analytical Chemistry 2022; 94(39) doi: 10.1021/acs.analchem.2c03100
82
Louise J. M. Alferink, Nicole S. Erler, Robert J. de Knegt, Harry L. A. Janssen, Herold J. Metselaar, Sarwa Darwish Murad, Jessica C. Kiefte-de Jong. Adherence to a plant-based, high-fibre dietary pattern is related to regression of non-alcoholic fatty liver disease in an elderly population. European Journal of Epidemiology 2020; 35(11) doi: 10.1007/s10654-020-00627-2
83
Ghada Hussein, Aljoharah A Al Saud, Abdulelah A Bashandi, Mohammed M Almousallam, Reem M AlShihri, Osama M Almousallam, Ibrahim M Binsalamah, Yaser Alendijani. Prevalence of Nonalcoholic Fatty Liver Disease at a Tertiary Care Center in Saudi Arabia. Cureus 2023;  doi: 10.7759/cureus.47896
84
Christine Tien, Daphne Remulla, Yong Kwon, Juliet Emamaullee. Contemporary strategies to assess and manage liver donor steatosis: a review. Current Opinion in Organ Transplantation 2021; 26(5) doi: 10.1097/MOT.0000000000000893
85
Teodora Biciusca, Sorina Ionelia Stan, Mara Amalia Balteanu, Ramona Cioboata, Alice Elena Ghenea, Suzana Danoiu, Ana-Maria Bumbea, Viorel Biciusca. The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review. Diagnostics 2023; 13(21) doi: 10.3390/diagnostics13213316
86
Mercedes del Río-Moreno, Emilia Alors-Pérez, Sandra González-Rubio, Gustavo Ferrín, Oscar Reyes, Manuel Rodríguez-Perálvarez, Marina E Sánchez-Frías, Rafael Sánchez-Sánchez, Sebastián Ventura, José López-Miranda, Rhonda D Kineman, Manuel de la Mata, Justo P Castaño, Manuel D Gahete, Raúl M Luque. Dysregulation of the Splicing Machinery Is Associated to the Development of Nonalcoholic Fatty Liver Disease. The Journal of Clinical Endocrinology & Metabolism 2019; 104(8) doi: 10.1210/jc.2019-00021
87
Arsenii V Telichko, Rehman Ali, Thurston Brevett, Huaijun Wang, Jose G Vilches-Moure, Sukumar U Kumar, Ramasamy Paulmurugan, Jeremy J Dahl. Noninvasive estimation of local speed of sound by pulse-echo ultrasound in a rat model of nonalcoholic fatty liver. Physics in Medicine & Biology 2022; 67(1) doi: 10.1088/1361-6560/ac4562
88
Uday Kumar Marri, Kumble Seetharama Madhusudhan. Dual-Energy Computed Tomography in Diffuse Liver Diseases. Journal of Gastrointestinal and Abdominal Radiology 2022; 5(02) doi: 10.1055/s-0042-1742432
89
Swasthika Gurjar, Ramanarayana Bhat A, Raghavendra Upadhya, Revathi P. Shenoy. Extracellular vesicle-mediated approaches for the diagnosis and therapy of MASLD: current advances and future prospective. Lipids in Health and Disease 2025; 24(1) doi: 10.1186/s12944-024-02396-3
90
Aylin Tahmasebi, Corinne E. Wessner, Flavius F. Guglielmo, Shuo Wang, Trang Vu, Ji-Bin Liu, Jesse Civan, Andrej Lyshchik, Flemming Forsberg, Hongbo Li, Enze Qu, John R. Eisenbrey. Comparison of Magnetic Resonance-Based Elastography and Ultrasound Shear Wave Elastography in Patients With Suspicion of Nonalcoholic Fatty Liver Disease. Ultrasound Quarterly 2023; 39(2) doi: 10.1097/RUQ.0000000000000638
91
Rohan Kelkar, Uday Phadke, Raveena Kelkar, Shalmi Khanapurkar, Nishad A Barve. Significance of Correlation of Shear Wave Elastography With Fibrosis-4 in a Cohort of Patients With Diabetes and Nonalcoholic Fatty Liver Disease. Cureus 2024;  doi: 10.7759/cureus.67015
92
Gerhard Nygaard. On a Novel, Simplified Model Framework Describing Ascorbic Acid Concentration Dynamics. 2019 41st Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) 2019;  doi: 10.1109/EMBC.2019.8857675
93
Fuminori Hyodo, Hinako Eto, Tatsuya Naganuma, Norikazu Koyasu, Abdelazim Elsayed Elhelaly, Yoshifumi Noda, Hiroki Kato, Masaharu Murata, Tomohiko Akahoshi, Makoto Hashizume, Hideo Utsumi, Masayuki Matsuo. In Vivo Dynamic Nuclear Polarization Magnetic Resonance Imaging for the Evaluation of Redox-Related Diseases and Theranostics . Antioxidants & Redox Signaling 2022; 36(1-3) doi: 10.1089/ars.2021.0087
94
Terence B. Lee, Martin T. W. Kueh, Vardhmaan Jain, Alexander C. Razavi, Pamela Alebna, Nicholas W. S. Chew, Anurag Mehta. Biomarkers of Hepatic Dysfunction and Cardiovascular Risk. Current Cardiology Reports 2023; 25(12) doi: 10.1007/s11886-023-01993-5
95
Zaki A. Sherif. Nonalcoholic Fatty Liver Disease - An Update. 2019;  doi: 10.5772/intechopen.85780
96
Xiaolu Weng, Jing Xu, Shouxing Yang. Association between the arm circumference and non-alcoholic fatty liver disease in American children and adolescence: a population-based analysis. Frontiers in Public Health 2024; 12 doi: 10.3389/fpubh.2024.1323795
97
Joachim Richter, Andreas Neumayr, Amadou Garba-Djirmay, Hiroshi Ohmae, Ralph Aniceto, Xiao-Nong Zhou, Jing Xu, Zhaoyu Guo, An Ning, Edward Mberu Kamau, Francesca Tamarozzi, Hannah Wei Wu, Charles King, Birgitte Jyding Vennervald, Goylette F. Chami, Jürg Utzinger, Christoph Hatz. The Basel ultrasonography protocol for assessing hepatosplenic pathologies in Asian schistosomiasis: report of a WHO expert meeting. Infectious Diseases of Poverty 2025; 14(1) doi: 10.1186/s40249-025-01349-x
98
Duanghathai Pasanta, Khin Thandar Htun, Jie Pan, Montree Tungjai, Siriprapa Kaewjaeng, Hongjoo Kim, Jakrapong Kaewkhao, Suchart Kothan. Magnetic Resonance Spectroscopy of Hepatic Fat from Fundamental to Clinical Applications. Diagnostics 2021; 11(5) doi: 10.3390/diagnostics11050842
99
Adriana Romero, Christopher Khan, Sebastian Merino, Brett Byram, Roberto Lavarello. Evaluation of the Effect of Clutter Reduction in Attenuation Coefficient Estimation. 2025 IEEE International Ultrasonics Symposium (IUS) 2025;  doi: 10.1109/IUS62464.2025.11201456
100
Evdoxia Gitsi, Alexander Kokkinos, Sofia K. Konstantinidou, Sarantis Livadas, Georgia Argyrakopoulou. The Relationship between Resting Metabolic Rate and Body Composition in People Living with Overweight and Obesity. Journal of Clinical Medicine 2024; 13(19) doi: 10.3390/jcm13195862
101
Isabel Molwitz, Miriam Leiderer, Cansu Özden, Jin Yamamura. Dual-Energy Computed Tomography for Fat Quantification in the Liver and Bone Marrow: A Literature Review. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren 2020; 192(12) doi: 10.1055/a-1212-6017
102
Luigi Mirarchi, Simona Amodeo, Roberto Citarrella, Anna Licata, Maurizio Soresi, Lydia Giannitrapani. SGLT2 Inhibitors as the Most Promising Influencers on the Outcome of Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2022; 23(7) doi: 10.3390/ijms23073668
103
Rita Basu, Mazen Noureddin, Jeanne M. Clark. Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers. Mayo Clinic Proceedings 2022; 97(9) doi: 10.1016/j.mayocp.2022.04.005
104
Mengyuan Wang, Mingxing Chang, Peipu Shen, Wei Wei, Huayao Li, Guifang Shen. Application value of triglyceride-glucose index and triglyceride-glucose body mass index in evaluating the degree of hepatic steatosis in non-alcoholic fatty liver disease. Lipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-023-01954-5
105
Zhijin Wang, Bing Cai, Wen Yang, Peisong Zhang, Yaohui Huang, Jinmo Tang. Learning High-dimensional Associations for Nonalcoholic Fatty Liver Disease Diagnosis Prediction. 2022 IEEE Smartworld, Ubiquitous Intelligence & Computing, Scalable Computing & Communications, Digital Twin, Privacy Computing, Metaverse, Autonomous & Trusted Vehicles (SmartWorld/UIC/ScalCom/DigitalTwin/PriComp/Meta) 2022;  doi: 10.1109/SmartWorld-UIC-ATC-ScalCom-DigitalTwin-PriComp-Metaverse56740.2022.00052
106
Naoki Tanaka, Takefumi Kimura, Naoyuki Fujimori, Tadanobu Nagaya, Michiharu Komatsu, Eiji Tanaka. Current status, problems, and perspectives of non-alcoholic fatty liver disease research. World Journal of Gastroenterology 2019; 25(2): 163-177 doi: 10.3748/wjg.v25.i2.163
107
Mohamed El-Kassas, Heba A. Othman, Mohamed Elbadry, Khalid Alswat, Yusuf Yilmaz. Risk Stratification of Patients with Metabolic Dysfunction-associated Steatotic Liver Disease: Steatohepatitis, Fibrosis, and Hepatocellular Carcinoma. Journal of Clinical and Experimental Hepatology 2025; 15(1) doi: 10.1016/j.jceh.2024.102415
108
Xinting Cai, Barbara Thorand, Simon Hohenester, Cornelia Prehn, Alexander Cecil, Jerzy Adamski, Tanja Zeller, Andrea Dennis, Rajarshi Banerjee, Annette Peters, Hanieh Yaghootkar, Jana Nano. Association of sex hormones and sex hormone-binding globulin with liver fat in men and women: an observational and Mendelian randomization study. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1223162
109
John A. Dougherty, Erenie Guirguis, Krisy-Ann Thornby. A Systematic Review of Newer Antidiabetic Agents in the Treatment of Nonalcoholic Fatty Liver Disease. Annals of Pharmacotherapy 2021; 55(1) doi: 10.1177/1060028020935105
110
Evy Yunihastuti, Lusiani Rusdi, Muhammad Syahrir Azizi, Riwanti Estiasari, Chyntia Olivia Maurine Jasirwan, Endah Ayu T. Wulandari, Dyah Purnamasari, Mutiara Shinta Noviar, Sally Aman Nasution. Effect of atorvastatin on subclinical atherosclerosis in virally-suppressed HIV-infected patients with CMV seropositivity: a randomized double-blind placebo-controlled trial. F1000Research 2021; 10 doi: 10.12688/f1000research.28262.1
111
Arun J. Sanyal, Sudha S. Shankar, Roberto A. Calle, Anthony E. Samir, Claude B. Sirlin, Sarah P. Sherlock, Rohit Loomba, Kathryn J. Fowler, Clayton A. Dehn, Helen Heymann, Tania N. Kamphaus. Non-Invasive Biomarkers of Nonalcoholic Steatohepatitis: the FNIH NIMBLE project. Nature Medicine 2022; 28(3) doi: 10.1038/s41591-021-01652-8
112
P. Barton Duell, Francine K. Welty, Michael Miller, Alan Chait, Gmerice Hammond, Zahid Ahmad, David E. Cohen, Jay D. Horton, Gregg S. Pressman, Peter P. Toth. Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology 2022; 42(6) doi: 10.1161/ATV.0000000000000153
113
Ignat Drozdov, Benjamin Szubert, Ian A. Rowe, Timothy J. Kendall, Jonathan A. Fallowfield. Accurate prediction of all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease using electronic health records. Annals of Hepatology 2024; 29(5) doi: 10.1016/j.aohep.2024.101528
114
Soumalya Sarkar, Deepika Kumari, Sonu Kumar Gupta, Vipin Sharma, Sumedha Mukhi, Parul Kamboj, Vedula Sasibhushan, Rajiva Kumar Rai, Sastry Lakshminarayana Jatavallabhula, Dinesh Mahajan, Yashwant Kumar, Ajay Kumar, Madhu Dikshit. Saroglitazar and Hepano treatment offers protection against high fat high fructose diet induced obesity, insulin resistance and steatosis by modulating various class of hepatic and circulating lipids. Biomedicine & Pharmacotherapy 2021; 144 doi: 10.1016/j.biopha.2021.112357
115
Maria Martin-Grau, Vannina G Marrachelli, Daniel Monleon. Rodent models and metabolomics in non-alcoholic fatty liver disease: What can we learn?. World Journal of Hepatology 2022; 14(2): 304-318 doi: 10.4254/wjh.v14.i2.304
116
Szilárd Váncsa, Dávid Németh, Péter Hegyi, Zsolt Szakács, Péter Jeno Hegyi, Dániel Pécsi, Alexandra Mikó, Bálint Erőss, Adrienn Erős, Gabriella Pár. Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease Worsen the Outcome in Acute Pancreatitis: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine 2020; 9(9) doi: 10.3390/jcm9092698
117
Nikolina-Alexia Fasoula, Angelos Karlas, Olga Prokopchuk, Nikoletta Katsouli, Michail Bariotakis, Evangelos Liapis, Anna Goetz, Michael Kallmayer, Josefine Reber, Alexander Novotny, Helmut Friess, Marc Ringelhan, Roland Schmid, Hans-Henning Eckstein, Susanna Hofmann, Vasilis Ntziachristos. Non-invasive multispectral optoacoustic tomography resolves intrahepatic lipids in patients with hepatic steatosis. Photoacoustics 2023; 29 doi: 10.1016/j.pacs.2023.100454
118
S. Karthigaiveni, D. Jayasutha, A. Mohamed Anwar, R. Sabin Begum, S. Vidhya, S. P. Santhoshkumar. Recognition of a Robust Fatty Liver Image Using Generative Adversarial Networks (GANs). 2025 International Conference on Information, Implementation, and Innovation in Technology (I2ITCON) 2025;  doi: 10.1109/I2ITCON65200.2025.11210583
119
Omar Elshaarawy, Johannes Mueller, Sina Straub, Sebastian Mueller. Nicht-alkoholische Fettlebererkrankung. 2022;  doi: 10.1007/978-3-662-62484-5_13
120
Mojtaba Malek, Mohammad E. Khamseh, Haleh Chehrehgosha, Sohrab Nobarani, Fariba Alaei-Shahmiri. Triglyceride glucose-waist to height ratio: a novel and effective marker for identifying hepatic steatosis in individuals with type 2 diabetes mellitus. Endocrine 2021; 74(3) doi: 10.1007/s12020-021-02815-w
121
Samira Saraya, Mahmoud Saraya, Mohamed Mahmoud, Mohamed Galal, Hazem Hamed Soliman, Mariam Raafat. The associations between coronary artery disease, and non-alcoholic fatty liver disease by computed tomography. The Egyptian Heart Journal 2021; 73(1) doi: 10.1186/s43044-021-00222-0
122
Xingxin Huang, Yuan-E Lian, Lida Qiu, XunBin Yu, Jikui Miao, Shichao Zhang, Zheng Zhang, Xiong Zhang, Jianxin Chen, Yannan Bai, Lianhuang Li. Quantitative Assessment of Hepatic Steatosis Using Label-Free Multiphoton Imaging and Customized Image Processing Program. Laboratory Investigation 2023; 103(10) doi: 10.1016/j.labinv.2023.100223
123
Flavia Noelia Mazzini, Frank Cook, John Gounarides, Sebastián Marciano, Leila Haddad, Ana Jesica Tamaroff, Paola Casciato, Adrián Narvaez, María Florencia Mascardi, Margarita Anders, Federico Orozco, Nicolás Quiróz, Marcelo Risk, Susana Gutt, Adrián Gadano, Celia Méndez García, Martin L. Marro, Alberto Penas-Steinhardt, Julieta Trinks. Plasma and stool metabolomics to identify microbiota derived-biomarkers of metabolic dysfunction-associated fatty liver disease: effect of PNPLA3 genotype. Metabolomics 2021; 17(7) doi: 10.1007/s11306-021-01810-6
124
Eri G. Osta, Florentino Saenz Rios, Sriram Jaganathan, Courtney Thomas, Eugenia Tsai, Venkateswar Surabhi, Srinivasa R. Prasad, Venkata S. Katabathina. Current Update on Nomenclature, Diagnosis, and Management of Metabolic Dysfunction–associated Steatotic Liver Disease: Radiologists’ Perspective. RadioGraphics 2025; 45(12) doi: 10.1148/rg.240221
125
Prevalence of non‐alcoholic fatty liver disease and factors associated with it in Indian women with a history of gestational diabetes mellitus. Journal of Diabetes Investigation 2021; 12(5) doi: 10.1111/jdi.13411
126
Doina Georgescu, Ana Lascu, Ioana Ionita, Oana-Elena Ancusa, Mihai Ionita, Ciprian Rosca, Despina Calamar-Popovici, Daniel Lighezan. Advances in Probiotics for Health and Nutrition. 2024;  doi: 10.5772/intechopen.110134
127
Fuad Jafarov, Eda Kaya, Alev Bakir, Fatih Eren, Yusuf Yilmaz. The diagnostic utility of fibrosis-4 or nonalcoholic fatty liver disease fibrosis score combined with liver stiffness measurement by fibroscan in assessment of advanced liver fibrosis: a biopsy-proven nonalcoholic fatty liver disease study. European Journal of Gastroenterology & Hepatology 2020; 32(5) doi: 10.1097/MEG.0000000000001573
128
Gashaw Hassen, Abhishek Singh, Gizeshwork Belete, Nidhi Jain, Ivonne De la Hoz, Genesis P Camacho-Leon, Nitsuh K Dargie, Keila G Carrera, Tadesse Alemu, Sharan Jhaveri, Nebiyou Solomon. Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease. Cureus 2022;  doi: 10.7759/cureus.25495
129
Noha Adel Yassin, Ebtehal Mahmoud Ahmed, Wessam Abdelrahman Elzayat, Sawsan Hassan Okasha, Noha Arafa. Quantitative assessment of liver stiffness using 2D-shear wave elastography in Egyptian children suspected metabolically-dysfunction-associated steatotic liver disease. Egyptian Pediatric Association Gazette 2026; 74(1) doi: 10.1186/s43054-026-00516-5
130
Julio Plaza-Díaz, Patricio Solis-Urra, Jerónimo Aragón-Vela, Fernando Rodríguez-Rodríguez, Jorge Olivares-Arancibia, Ana I. Álvarez-Mercado. Insights into the Impact of Microbiota in the Treatment of NAFLD/NASH and Its Potential as a Biomarker for Prognosis and Diagnosis. Biomedicines 2021; 9(2) doi: 10.3390/biomedicines9020145
131
Sin Hye Park, Dong Jin Kim. Correlation Between Liver-to-Spleen Hounsfield Unit Ratio and Metabolic Improvement in Patients With Bariatric Surgery. Journal of Metabolic and Bariatric Surgery 2025; 14(1) doi: 10.17476/jmbs.2025.14.1.24
132
Charalampia Amerikanou, Stavroula Kanoni, Andriana C. Kaliora, Angela Barone, Mladen Bjelan, Giuseppe D'Auria, Aristea Gioxari, María José Gosalbes, Sofia Mouchti, Maria G. Stathopoulou, Beatriz Soriano, Stefan Stojanoski, Rajarshi Banerjee, Maria Halabalaki, Eleni V. Mikropoulou, Aimo Kannt, John Lamont, Carlos Llorens, Fernando Marascio, Miriam Marascio, Francisco J. Roig, Ilias Smyrnioudis, Iraklis Varlamis, Sophie Visvikis‐Siest, Milan Vukic, Natasa Milic, Milica Medic‐Stojanoska, Lucia Cesarini, Jonica Campolo, Amalia Gastaldelli, Panos Deloukas, Maria Giovanna Trivella, M. Pilar Francino, George V. Dedoussis. Effect of Mastiha supplementation on NAFLD: The MAST4HEALTH Randomised, Controlled Trial. Molecular Nutrition & Food Research 2021; 65(10) doi: 10.1002/mnfr.202001178
133
Andrew L. Wang, Orin Mishkit, Heather Mao, Lakshmi Arivazhagan, Tony Dong, Frances Lee, Aparajita Bhattacharya, P. Douglas Renfrew, Ann Marie Schmidt, Youssef Z. Wadghiri, Edward A. Fisher, Jin Kim Montclare. Collagen-targeted protein nanomicelles for the imaging of non-alcoholic steatohepatitis. Acta Biomaterialia 2024; 187 doi: 10.1016/j.actbio.2024.08.052
134
Mayur Virarkar, Ajaykumar C. Morani, Melissa W. Taggart, Priya Bhosale. Liver Fibrosis Assessment. Seminars in Ultrasound, CT and MRI 2021; 42(4) doi: 10.1053/j.sult.2021.03.003
135
Cornelius von Morze, Tyler Blazey, Mark S. Conradi. Quantifying Liver Fat Using a Low-Field Unilateral MR System. Applied Magnetic Resonance 2023; 54(11-12) doi: 10.1007/s00723-023-01595-y
136
Dominika Maciejewska, Joanna Palma, Karolina Dec, Karolina Skonieczna-Żydecka, Izabela Gutowska, Małgorzata Szczuko, Karolina Jakubczyk, Ewa Stachowska. Is the Fatty Acids Profile in Blood a Good Predictor of Liver Changes? Correlation of Fatty Acids Profile with Fatty Acids Content in the Liver. Diagnostics 2019; 9(4) doi: 10.3390/diagnostics9040197
137
Alejandro Campos-Murguía, Astrid Ruiz-Margáin, José A González-Regueiro, Ricardo U Macías-Rodríguez. Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease. World Journal of Gastroenterology 2020; 26(39): 5919-5943 doi: 10.3748/wjg.v26.i39.5919
138
Waqas B. Khalid, Xucai Chen, Kang Kim. Multifocus Thermal Strain Imaging Using a Curved Linear Array Transducer for Identification of Lipids in Deep Tissue. Ultrasound in Medicine & Biology 2021; 47(7) doi: 10.1016/j.ultrasmedbio.2021.03.005
139
Andrew O Odegaard, David R Jacobs, Jr, Lisa B Van Wagner, Mark A Pereira. Levels of abdominal adipose tissue and metabolic-associated fatty liver disease (MAFLD) in middle age according to average fast-food intake over the preceding 25 years: the CARDIA Study. The American Journal of Clinical Nutrition 2022; 116(1) doi: 10.1093/ajcn/nqac079
140
Arto Korkiakoski, Aki J. Käräjämäki, Justiina Ronkainen, Juha Auvinen, Jokke Hannuksela, Y. Antero Kesäniemi, Olavi Ukkola. Nonalcoholic fatty liver disease and its prognosis associates with shorter leucocyte telomeres in a 21-year follow-up study. Scandinavian Journal of Clinical and Laboratory Investigation 2022; 82(3) doi: 10.1080/00365513.2022.2059698
141
G. Grzych, L. Bernard, R. Lestrelin, A. Tailleux, B. Staels. État des lieux sur la physiopathologie, le diagnostic et les traitements de la stéato-hépatite non alcoolique (NASH). Annales Pharmaceutiques Françaises 2023; 81(2) doi: 10.1016/j.pharma.2022.09.005
142
Jiajia Yang, Liwu Lin, Ensheng Xue, Dengke Hong, Yan Yang, Meifang Xu, Zhikui Chen. Can Nonfibrotic Nonalcoholic Steatohepatitis Be Effectively Identified by Supersonic Shear Imaging?. Analytical Cellular Pathology 2019; 2019 doi: 10.1155/2019/2013674
143
Hyperpolarized Carbon-13 Magnetic Resonance Imaging and Spectroscopy. Advances in Magnetic Resonance Technology and Applications 2021; 3 doi: 10.1016/B978-0-12-822269-0.00003-8
144
Hanchen Ma, Wenjie Zhang, Zheng Zhao, Shuaichen Jin, Linchuan Li, Ruizhao Zong, Wuyang Li, Ziwei Zhang, Shichang Cui, Yunmiao Pan, Jiankang Zhu, Guangyong Zhang. Association between triglyceride-glucose related indices and at-risk NASH in U.S. adults with NAFLD: results from NHANES 2017-2020. Frontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1604991
145
Aiko Takami, Masaru Kato, Yasuhito Kotake, Akihiro Okamura, Takuya Tomomori, Shunsuke Kawatani, Fumiyasu Hirano, Kazuhiro Yamamoto. Impact of Metabolic Dysfunction-Associated Fatty Liver Disease on Atrial Fibrillation Recurrence After Ablation　― A Retrospective Study in Japanese Patients ―. Circulation Journal 2025; 90(1) doi: 10.1253/circj.CJ-25-0169
146
Krishnan Silja, Natarajan Selvaganabathy, Thiyagarajan Kalaiselvi, Chinnasamy Thirunavukkarasu. Inhibition of glutathione generation in hepatic steatotic rats augments oxidative stress. Toxicology Mechanisms and Methods 2023; 33(7) doi: 10.1080/15376516.2023.2202784
147
Eman Mahmoud Barakat, Iman Fawzy Montasser, Doaa Zakaria Zaky, Yasser Arafat Abdelrazik, Hoda Mohammed Farid, Ahmed El Dorry, Mohammed Kamal Shaker. Outcome of MAFLD-related HCC in Egyptian patients: a single center study. Egyptian Liver Journal 2024; 14(1) doi: 10.1186/s43066-024-00337-4
148
Sofia Garcês Soares, Renato Medas, Filipe Conceição, Roberto Silva, José Artur Paiva, Ana Cristina Carneiro. Hepatic Glycogenosis: An Underdiagnosed Entity?. Cureus 2022;  doi: 10.7759/cureus.23853
149
Julie Poirier, Chloé Cloteau, Audrey Aguesse, Xavier Billot, Etienne Thévenot, Michel Krempf, René Valéro, Marie Maraninchi, Mikaël Croyal. Bariatric Surgery Improves the Atherogenic Profile of Circulating Methylarginines in Obese Patients: Results from a Pilot Study. Metabolites 2021; 11(11) doi: 10.3390/metabo11110759
150
Azin S. Janani, Sasan Ahdi Rezaeieh, Amin Darvazehban, Shelley E. Keating, Amin M. Abbosh. Portable Electromagnetic Device for Steatotic Liver Detection Using Blind Source Separation and Shannon Wavelet Entropy. IEEE Journal of Electromagnetics, RF and Microwaves in Medicine and Biology 2022; 6(4) doi: 10.1109/JERM.2022.3205247
151
Hina Arif-Tiwari, Kristin K. Porter, Ihab R. Kamel, Mustafa R. Bashir, Alice Fung, David E. Kaplan, Brendan M. McGuire, Gregory K. Russo, Elainea N. Smith, Lilja Bjork Solnes, Kiran H. Thakrar, Abhinav Vij, Shaun A. Wahab, Richard M. Wardrop, Atif Zaheer, Laura R. Carucci. ACR Appropriateness Criteria® Abnormal Liver Function Tests. Journal of the American College of Radiology 2023; 20(11) doi: 10.1016/j.jacr.2023.08.023
152
Sadhna Dhingra, Juhi D. Mahadik, Yaman Tarabishy, Sarah B. May, John M. Vierling. Prevalence and clinical significance of portal inflammation, portal plasma cells, interface hepatitis and biliary injury in liver biopsies from patients with non-alcoholic steatohepatitis. Pathology 2022; 54(6) doi: 10.1016/j.pathol.2022.01.009
153
Akira Yamada, Eriko Yoshizawa. Quantitative assessment of liver steatosis using ultrasound: dual-energy CT. Journal of Medical Ultrasonics 2021; 48(4) doi: 10.1007/s10396-021-01136-9
154
Xiaowu Yuan, Jian Dong, XuHong Qin, Ting Ma, Jin Tong, Ming Chen, XiaoYan Ge, YanFei Kang, SiRui Wang, JinLi Wang, Jun Li, XinWu Cui. Multidimensional Reliability Assessment of the Hepato‐Renal Index for Pediatric Metabolic Dysfunction‐Associated Fatty Liver Disease Diagnosis. Journal of Clinical Ultrasound 2026;  doi: 10.1002/jcu.70215
155
You-Wei Li, Yang Jiao, Na Chen, Qiang Gao, Yu-Kun Chen, Yuan-Fang Zhang, Qi-Ping Wen, Zong-Ming Zhang. How to select the quantitative magnetic resonance technique for subjects with fatty liver: A systematic review. World Journal of Clinical Cases 2022; 10(25): 8906-8921 doi: 10.12998/wjcc.v10.i25.8906
156
Shen Tian, Hao Li, Renhua Li, Liang Ran, Shu Li, Juan Wu, Zhou Xu, Xinyu Liang, Yuling Chen, Jun Xiao, Jiaying Wei, Chenyu Ma, Jingyu Song, Ruiling She, Kainan Wu, Lingquan Kong. Prevalence of hepatic steatosis and metabolic associated fatty liver disease among female breast cancer survivors. Chinese Medical Journal 2022; 135(19) doi: 10.1097/CM9.0000000000002121
157
Mark E. Lockhart, Andrew D. Smith. Fatty Liver Disease: Artificial Intelligence Takes on the Challenge. Radiology 2020; 295(2) doi: 10.1148/radiol.2020200058
158
Shen Chen, Juan Pang, Rong Huang, Yiran You, Haoyang Zhang, Hongliang Xue, Xu Chen. Associations of Macronutrients Intake With MRI-determined Hepatic Fat Content, Hepatic Fibroinflammation, and NAFLD. The Journal of Clinical Endocrinology & Metabolism 2023; 108(12) doi: 10.1210/clinem/dgad346
159
Dong Hee Lee, Il Jo, Hye Sun Lee, Jeonghyun Kang. Combined impact of myosteatosis and liver steatosis on prognosis in stage I–III colorectal cancer patients. Journal of Cachexia, Sarcopenia and Muscle 2023; 14(6) doi: 10.1002/jcsm.13369
160
Xun-Xun Chen, Hui-Ting Shi, Li-Li Xiao, Huan Li, Bin-Bin Du, Zhen Huang, Dian-Hong Zhang, Lei-Ming Wu, Li-Na Wu, Jie-Lei Zhang. Identification of the E3 ligase TRIM21 as a crucial regulator of STAT1 in metabolic dysfunction—associated steatohepatitis. Cell Communication and Signaling 2026; 24(1) doi: 10.1186/s12964-026-02668-8
161
Nina Gyorfi, Adrian Robert Gal, Andras Fincsur, Karoly Kalmar-Nagy, Kitti Mintal, Edina Hormay, Attila Miseta, Tamas Tornoczky, Anita Katalin Nemeth, Peter Bogner, Tamas Kiss, Zsuzsanna Helyes, Zoltan Sari, Mihaly Klincsik, Vladimir Tadic, Laszlo Lenard, Andras Vereczkei, Zoltan Karadi, Zoltan Vizvari, Attila Toth. Novel Noninvasive Paraclinical Study Method for Investigation of Liver Diseases. Biomedicines 2023; 11(9) doi: 10.3390/biomedicines11092449
162
Alexa M. Giammarino, He Qiu, Kishen Bulsara, Sabrina Khan, Yu Jiang, Ben L. Da, David E. Bernstein, Sanjaya K. Satapathy. Community Socioeconomic Deprivation Predicts Nonalcoholic Steatohepatitis. Hepatology Communications 2022; 6(3) doi: 10.1002/hep4.1831
163
Haoxuan Zou, Xiaopu Ma, Fan Zhang, Yan Xie. Comparison of the diagnostic performance of twelve noninvasive scores of metabolic dysfunction-associated fatty liver disease. Lipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-023-01902-3
164
Magdalena Swiatek-de Lange, Bruno Köhler, Marta Bes, Juan Ignacio Esteban, Wattana Sukeepaisarnjaroen, Satawat Thongsawat, Tawesak Tanwandee, Teerha Piratvisuth, Henry Lik-Yuen Chan, Vinzent Rolny, Martin Klammer, Juliane Malik. Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma. World Journal of Gastroenterology 2022; 28(29): 3917-3933 doi: 10.3748/wjg.v28.i29.3917
165
Javier Espíldora-Hernández, Tania Díaz-Antonio, Javier Baena-Espinar, Inmaculada Alonso-Calderón, José Rioja, Emilio Alba-Conejo, Pedro Valdivielso, Miguel-Ángel Sánchez-Chaparro. Subclinical Arteriosclerosis is Associated with Common Vascular Risk Factors in Long-Term Survivors of Testicular Cancer. Journal of Clinical Medicine 2020; 9(4) doi: 10.3390/jcm9040971
166
Andrej Hari. Ultrasound Elastography—Cornerstone of Non-Invasive Metabolic Dysfunction-Associated Fatty Liver Disease Assessment. Medicina 2021; 57(6) doi: 10.3390/medicina57060516
167
Janna L. Morrison, Oyekoya T. Ayonrinde, Alison S. Care, Geoffrey D. Clarke, Jack R.T. Darby, Anna L. David, Justin M. Dean, Stuart B. Hooper, Marcus J. Kitchen, Christopher K. Macgowan, Andrew Melbourne, Erin V McGillick, Charles A. McKenzie, Navin Michael, Nuruddin Mohammed, Suresh Anand Sadananthan, Eric Schrauben, Timothy R.H. Regnault, S. Sendhil Velan. Seeing the fetus from a DOHaD perspective: discussion paper from the advanced imaging techniques of DOHaD applications workshop held at the 2019 DOHaD World Congress. Journal of Developmental Origins of Health and Disease 2021; 12(2) doi: 10.1017/S2040174420000884
168
Melissa Lopez-Pentecost, Martha Tamez, Josiemer Mattei, Elizabeth T. Jacobs, Cynthia A. Thomson, David O. Garcia. Adherence to a Traditional Mexican Diet Is Associated with Lower Hepatic Steatosis in US-Born Hispanics of Mexican Descent with Overweight or Obesity. Nutrients 2023; 15(23) doi: 10.3390/nu15234997
169
Helena Castañé, Gerard Baiges-Gaya, Anna Hernández-Aguilera, Elisabet Rodríguez-Tomàs, Salvador Fernández-Arroyo, Pol Herrero, Antoni Delpino-Rius, Nuria Canela, Javier A. Menendez, Jordi Camps, Jorge Joven. Coupling Machine Learning and Lipidomics as a Tool to Investigate Metabolic Dysfunction-Associated Fatty Liver Disease. A General Overview. Biomolecules 2021; 11(3) doi: 10.3390/biom11030473
170
Somaya Albhaisi, Arun J. Sanyal. Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date. Pharmaceutical Medicine 2019; 33(6) doi: 10.1007/s40290-019-00305-z
171
Justin J. O’Sullivan, Nathaniel H. O. Harder, Marie C. Heffern. Detecting liver disease via an endogenous pigment. Nature Biomedical Engineering 2020; 4(8) doi: 10.1038/s41551-020-0601-2
172
Vladimir T. Ivashkin, Marina V. Maevskaya, Elena N. Shirokova, Igor V. Maev, Alexey A. Samsonov, Evgeniy I. Sas, Liudmila K. Palgova, Kirill Starostin. Correlation of Objective Endpoints and Subjective Patient-Reported Outcomes in NAFLD Treatment with Essential Phospholipids: Real-World Data Based on Pooled Analysis of Observational Studies. Drugs - Real World Outcomes 2021; 8(3) doi: 10.1007/s40801-021-00250-x
173
Mariana Elorz, Alberto Benito-Boilos, Bertha Araceli Marin, Nuria Pérez Díaz del Campo, Jose Ignacio Herrero, Jose Ignacio Monreal, Josep A. Tur, J. Alfredo Martínez, Maria Angeles Zulet, Itziar Abete. Neck Circumference for NAFLD Assessment during a 2-Year Nutritional Intervention: The FLiO Study. Nutrients 2022; 14(23) doi: 10.3390/nu14235160
174
Hyo Won Lee, In-Jeong Lee, Soo-Jin Lee, Yu Rim Kim, Hwan Myung Kim. Highly Sensitive Two-Photon Lipid Droplet Tracker for In Vivo Screening of Drug Induced Liver Injury. ACS Sensors 2022; 7(4) doi: 10.1021/acssensors.1c02679
175
Haoxuan Zou, Jiejie Xie, Xiaopu Ma, Yan Xie, Xingshun Qi. The Value of TyG‐Related Indices in Evaluating MASLD and Significant Liver Fibrosis in MASLD. Canadian Journal of Gastroenterology and Hepatology 2025; 2025(1) doi: 10.1155/cjgh/5871321
176
Zhen Huang, Lei‐Ming Wu, Jie‐Lei Zhang, Abdelkarim Sabri, Shou‐Jun Wang, Gui‐Jun Qin, Chang‐Qing Guo, Hong‐Tao Wen, Bin‐Bin Du, Dian‐Hong Zhang, Ling‐Yao Kong, Xin‐Yu Tian, Rui Yao, Ya‐Peng Li, Cui Liang, Peng‐Cheng Li, Zheng Wang, Jin‐Yan Guo, Ling Li, Jian‐Zeng Dong, Yan‐Zhou Zhang. Dual Specificity Phosphatase 12 Regulates Hepatic Lipid Metabolism Through Inhibition of the Lipogenesis and Apoptosis Signal–Regulating Kinase 1 Pathways. Hepatology 2019; 70(4) doi: 10.1002/hep.30597
177
Arinc Ozturk, Ramin Mohammadi, Theodore T. Pierce, Sagar Kamarthi, Manish Dhyani, Joseph R. Grajo, Kathleen E. Corey, Raymond T. Chung, Atul K. Bhan, Jagpreet Chhatwal, Anthony E. Samir. Diagnostic Accuracy of Shear Wave Elastography as a Non-invasive Biomarker of High-Risk Non-alcoholic Steatohepatitis in Patients with Non-alcoholic Fatty Liver Disease. Ultrasound in Medicine & Biology 2020; 46(4) doi: 10.1016/j.ultrasmedbio.2019.12.020
178
Omer Vehbi Alpaydin, Eda Nur Duran, Ayse Hur Alpaydin, Iskender Ekinci, Seyma Dumur, Hafize Uzun, Murat Akarsu, Isa Yalcinkaya, Omur Tabak. The Importance of Serum Perilipin-2 Level as an Early Indicator of Inflammation in Non-Alcoholic Fatty Liver Disease. Diagnostics 2025; 16(1) doi: 10.3390/diagnostics16010106
179
Parul Kamboj, Soumalya Sarkar, Sonu Kumar Gupta, Neema Bisht, Deepika Kumari, Md. Jahangir Alam, Sagar Barge, Bhaswati Kashyap, Barsha Deka, Simanta Bharadwaj, Seydur Rahman, Partha Pratim Dutta, Jagat C. Borah, Narayan Chandra Talukdar, Sanjay K. Banerjee, Yashwant Kumar. Methanolic Extract of Lysimachia Candida Lindl. Prevents High-Fat High-Fructose-Induced Fatty Liver in Rats: Understanding the Molecular Mechanism Through Untargeted Metabolomics Study. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.653872
180
Juan Li, Shenglan Dai. Associations between metabolic score for visceral fat and nonalcoholic fatty liver disease (NAFLD) in US adults: A cross-sectional study based on NHANES 2017–2020. Medicine 2025; 104(46) doi: 10.1097/MD.0000000000045082
181
Anugayathri Jawahar, Beverly Gonzalez, Neelam Balasubramanian, William Adams, Ari Goldberg. Comparison of computed tomography hepatic steatosis criteria for identification of abnormal liver function and clinical risk factors, in incidentally noted fatty liver. European Journal of Gastroenterology & Hepatology 2020; 32(2) doi: 10.1097/MEG.0000000000001502
182
Nina Gyorfi, Akos Odry, Zoltan Karadi, Peter Odry, Tibor Szakall, Bojan Kuljic, Attila Toth, Zoltan Vizvari. Development of Bioimpedance-based Measuring Systems for Diagnosis of Non-alcoholic Fatty Liver Disease. 2021 IEEE 15th International Symposium on Applied Computational Intelligence and Informatics (SACI) 2021;  doi: 10.1109/SACI51354.2021.9465584
183
José A. Inia, Geurt Stokman, Elsbet J. Pieterman, Martine C. Morrison, Aswin L. Menke, Lars Verschuren, Martien P. M. Caspers, Martin Giera, J. Wouter Jukema, Anita M. van den Hoek, Hans M. G. Princen. Atorvastatin Attenuates Diet-Induced Non-Alcoholic Steatohepatitis in APOE*3-Leiden Mice by Reducing Hepatic Inflammation. International Journal of Molecular Sciences 2023; 24(9) doi: 10.3390/ijms24097818
184
Asad Izziddin Dajani, Branko Popovic. Essential phospholipids for nonalcoholic fatty liver disease associated with metabolic syndrome: A systematic review and network meta-analysis. World Journal of Clinical Cases 2020; 8(21): 5235-5249 doi: 10.12998/wjcc.v8.i21.5235
185
Telma Souza e Silva Gebara, Ingrid Felicidade, Giselle Nobre Costa, Marilia Zaparolli de Ramos, Ana Carolina Bonde, Giovani Palermo, Samuel Guemra, José Henrique de Souza Peres, Mário Sérgio Mantovani, Rodrigo Picheth Di Napoli, Antônio Carlos Ligocki Campos. Predictive factors to estimate the severity of nonalcoholic fatty liver disease in candidates for Roux-en-Y gastric bypass. Nutrition 2023; 116 doi: 10.1016/j.nut.2023.112190
186
J.A. Weintraub, G. Lopez Mitnik, B.A. Dye. Oral Diseases Associated with Nonalcoholic Fatty Liver Disease in the United States. Journal of Dental Research 2019; 98(11) doi: 10.1177/0022034519866442
187
Soumalya Sarkar, Sankarsan Bhattacharya, Md. Jahangir Alam, Rajni Yadav, Sanjay K. Banerjee. Hypoxia aggravates non-alcoholic fatty liver disease in presence of high fat choline deficient diet: A pilot study. Life Sciences 2020; 260 doi: 10.1016/j.lfs.2020.118404
188
N. S. Branovitskaya. Polymorphism of PNPLA3 and TM6SF2 genes in patients with nonalcoholic fatty liver disease resident at Gomel region. Health and Ecology Issues 2024; 21(3) doi: 10.51523/2708-6011.2024-21-3-06
189
Tatyana Kushner, Marcia Lange, Pamela A. Argiriadi, Rachel Meislin, Keith Sigel, Norah Terrault, Emma Rosenbluth, Carin Carroll, Theresa Worthington, Shaelyn O’Hara, Joanne Stone, Scott Friedman, Sonam Rosberger, Deborah Feldman, Rhoda Sperling. Prevalence, Risk Profiles, and National Implications of Nonalcoholic Fatty Liver Disease in Pregnant Individuals. Clinical Gastroenterology and Hepatology 2024; 22(1) doi: 10.1016/j.cgh.2023.03.031
190
Mayur Virarkar, Janio Szklaruk, Corey T. Jensen, Melissa W. Taggart, Priya Bhosale. What's New in Hepatic Steatosis. Seminars in Ultrasound, CT and MRI 2021; 42(4) doi: 10.1053/j.sult.2021.03.001
191
Matthew Collins, Keyur Patel. The Liver in Systemic Disease. 2023;  doi: 10.1002/9781119802181.ch17
192
Haiyan Chen, Siqi Dai, Yimin Fang, Liubo Chen, Kai Jiang, Qichun Wei, Kefeng Ding. Hepatic Steatosis Predicts Higher Incidence of Recurrence in Colorectal Cancer Liver Metastasis Patients. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.631943
193
Li Tan, Si-Qun Xu. Association between serum antibodies to oral microorganisms and nonalcoholic fatty liver disease in adults. BMC Oral Health 2024; 24(1) doi: 10.1186/s12903-024-05141-5
194
Fabio Lucio Stahlschmidt, Jean Rodrigo Tafarel, Carla Martinez Menini-Stahlschmidt, Cristina Pellegrino Baena, Guy Cloutier. Hepatorenal index for grading liver steatosis with concomitant fibrosis. PLOS ONE 2021; 16(2) doi: 10.1371/journal.pone.0246837
195
Mohammad E. Khamseh, Mojtaba Malek, Rowshanak Abbasi, Hoda Taheri, Maryam Lahouti, Fariba Alaei-Shahmiri. Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity. Metabolic Syndrome and Related Disorders 2021; 19(3) doi: 10.1089/met.2020.0109
196
Xiaomi Du, Natalie DeForest, Amit R. Majithia. Human Genetics to Identify Therapeutic Targets for NAFLD: Challenges and Opportunities. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.777075
197
Pallavi Gurung, Junmo Lim, Yong-Wan Kim. Preventing High Fat Diet-Induced Obesity and Related Hepatic Steatosis by Chlorin e6-Mediated Photodynamic Therapy. Pharmaceuticals 2024; 17(6) doi: 10.3390/ph17060729
198
Alina Boeriu, Daniela Dobru, Crina Fofiu. Non-Invasive Diagnostic of NAFLD in Type 2 Diabetes Mellitus and Risk Stratification: Strengths and Limitations. Life 2023; 13(12) doi: 10.3390/life13122262
199
Venkatram Krishnan. Response to a letter to the editor. Abdominal Radiology 2021; 46(2) doi: 10.1007/s00261-020-02697-y
200
Wesam Bahitham, Siraj Alghamdi, Ibrahim Omer, Ali Alsudais, Ilana Hakeem, Arwa Alghamdi, Reema Abualnaja, Faisal M. Sanai, Alexandre S. Rosado, Consolato M. Sergi. Double Trouble: How Microbiome Dysbiosis and Mitochondrial Dysfunction Drive Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. Biomedicines 2024; 12(3) doi: 10.3390/biomedicines12030550
201
Niki Katsiki, Amalia Gastaldelli, Dimitri P. Mikhailidis. Predictive models with the use of omics and supervised machine learning to diagnose non-alcoholic fatty liver disease: A “non-invasive alternative” to liver biopsy?. Metabolism 2019; 101 doi: 10.1016/j.metabol.2019.154010
202
Anh-Cang Phan, Hung-Phi Cao, Thi-Nguu-Huynh Le, Thanh-Ngoan Trieu, Thuong-Cang Phan. Improving liver lesions classification on CT/MRI images based on Hounsfield Units attenuation and deep learning. Gene Expression Patterns 2023; 47 doi: 10.1016/j.gep.2022.119289
203
Suguru Ikeda, Takaaki Sugihara, Yoshiki Hoshino, Yukako Matsuki, Takakazu Nagahara, Jun-ichi Okano, Sonoko Kitao, Youhei Fujioka, Kazuhiro Yamamoto, Hajime Isomoto. Pemafibrate Dramatically Ameliorated the Values of Liver Function Tests and Fibrosis Marker in Patients with Non-Alcoholic Fatty Liver Disease. Yonago Acta Medica 2020; 63(3) doi: 10.33160/yam.2020.08.009
204
Mahesh Mathew, Zachary C. Pope, Pamela J. Schreiner, David R. Jacobs, Lisa B. VanWagner, James G. Terry, Mark A. Pereira. Non‐alcoholic fatty liver modifies associations of body mass index and waist circumference with cardiometabolic risk: The CARDIA study. Obesity Science & Practice 2024; 10(2) doi: 10.1002/osp4.751
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.